Our DEI Task Force provides an update on key developments, media coverage and commentary, and current litigation.
March 13, 2024
An overview of intellectual property considerations in M&A transactions, which can impact valuation and the ability to operate after closing.
March 13, 2024
We are pleased to provide you with Gibson Dunn’s ESG update covering the following key developments during February 2024.
March 13, 2024
Private equity is a growing presence in the healthcare sector, but that trend has drawn a backlash from federal and state regulators.
March 13, 2024
In vacating the NLRB’s new 2023 joint employer rule, the Texas district court determined that the test set forth in the rule is contrary to the National Labor Relations Act.
March 12, 2024
Our lawyers provide a summary of recent developments and upcoming legislative changes in German corporate law that will impact the M&A market this year.
March 12, 2024
Gibson Dunn lawyers summarize recent decisions issued by U.S. federal courts in cases challenging DEI initiatives.
March 11, 2024
An Overview of the Highlights and Key Differences to the Proposed Rules
March 8, 2024
Gibson Dunn's lawyers bring you the latest in U.S. derivatives news from the past week.
March 8, 2024
Our Life Sciences update provides a recap of 2023 highlights for capital markets, M&A activity, royalty finance transactions, and clinical funding arrangements, along with expectations for 2024.
March 8, 2024
Our Corporate Resolutions Update reports key statistics regarding U.S. Department of Justice non-prosecution agreements, deferred prosecution agreements (DPA), and corporate enforcement policy disgorgement since 2000; reports key statistics on guilty pleas between 2022 and 2023; assesses recent developments regarding enforcement policy and DPA regimes abroad; and summarizes the 31 agreements from July to December 2023.
March 7, 2024
Our Federal Circuit Update summarizes the current status of several petitions pending before the U.S. Supreme Court, as well as recent Federal Circuit decisions concerning printed publications, written description, claim construction, and inequitable conduct.
March 5, 2024
Our lawyers provide a year-end update on the False Claims Act (FCA), including significant enforcement developments.
March 4, 2024
Gibson Dunn's lawyers bring you the latest in U.S. derivatives news from the past week.
March 1, 2024
Our lawyers review the new compliance requirements in key technology sectors proposed by the U.S. Commerce Department.
February 29, 2024
The decision raises questions as to the validity of certain stockholder consent and designation-related rights found in many public and private company stockholder agreements.
February 28, 2024
Our DEI Task Force provides an update on key developments, media coverage and commentary, and current litigation.
February 28, 2024
Gibson Dunn lawyers address clients’ frequently asked questions about government shutdowns.
February 27, 2024
This update highlights steps taken by the Food and Drug Administration to implement the Modernization of Cosmetics Regulation Act since its enactment in 2022 as well as actions expected in the cosmetics space this year.
February 27, 2024
On February 23, the Texas Supreme Court unanimously held that an insured suffers a “loss”—and a claimant can sue the insurers directly—when the claimant and the insured settle, and the claimant agrees to look solely to the liability insurance policy for any recovery. But, because the insured doesn’t face liability beyond the insurance proceeds, the insurer isn’t bound by the settlement agreement during the subsequent coverage litigation.
February 27, 2024